Lehigh Valley Health Network (Data Collection Only)

Allentown, Pennsylvania 18103

4 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, Castration-resistant Prostate Cancer, Clinical Stage: Stage II (T3-4, N-), ER+ Breast Cancer, Glioblastoma, Glioma, HER2+ Breast Cancer, Lung Cancer, Lung Metastases, Melanoma, Metastatic Breast Cancer, Metastatic Breast Carcinoma

Studies at this site

• Pembrolizumab, Olaparib, and Temozolomide for People With Glioma — Recruiting now
• A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer — Recruiting now
• Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer — Recruiting now
• Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors — Recruiting now
• A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma — Running, not enrolling
• A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy — Running, not enrolling
• Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma — Running, not enrolling
• A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer — Completed
• Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma — Completed
• Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis — Completed